Alexander Karen sold $15K of BKKT

Alexander Karen (Chief Financial Officer) sold 1,907 shares of Bakkt, Inc. (BKKT) at $7.93 on 2026-06-25.

Original reporting
SEC EDGAR · Alexander Karen
Published Jun 29, 2026, 10:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 10:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BKKT
Neutral
medium confidence
Mentioned
$BKKT
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BKKTNeutralLow
01

Why it matters

The disclosure updates insider activity records; it can influence short-term sentiment but does not provide new fundamentals (no guidance, contracts, or regulatory actions).

02

Market read

Traders may monitor BKKT for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

The article lacks context on total compensation, prior sale cadence, and whether the sale was tax-related; also no 10b5-1 plan is cited, which can change how traders interpret intent.

Relevance 3/10Novelty 5/10Timing: new Form 4 filed 2026-06-29 (covers sale dated 2026-06-25)

Background

This is an SEC Form 4 insider transaction disclosure for Bakkt, Inc. (BKKT).

Company-level read

Ticker impact

$BKKTNeutralMedium confidence
Context

CFO Alexander Karen filed a Form 4 open-market sale of 1,907 BKKT shares at $7.93 on 2026-06-25.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.

Evidence & confidence

The filing is a direct open-market sale with no 10b5-1 plan stated, but the article provides no earnings, guidance, or operational change—so the information is mostly sentiment/positioning related.

Market effects

Minimal; insider sale does not indicate sector-wide change.

None indicated.

None indicated.

Counterpoint

Insider sales are often diversification or liquidity-driven and may not reflect negative company outlook, especially without any accompanying negative operational news.

Key entities

  • Bakkt, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Alexander Karen

    Chief Financial Officer who sold shares via an open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BKKTMed

Bakkt (BKKT) Q3 2026 Earnings Call Transcript

Bakkt (BKKT) reported Q3 2026 earnings, highlighting a 25-point gain in partners and distribution and a 15-point increase in operational efficiency. Total transacting volume was $147.9 million, with a $3 billion full-year target and $6 billion for the first half of 2027. The company expects growth from institutional and cross-border clients, with monthly reporting starting in December.

$BKKTMed

Bakkt Inc (BKKT) (Q3 2026) Earnings Call Highlights: Transformation Complete as Cost

Bakkt Inc (BKKT) reported Q3 2026 revenue of $149.2M, down from $402.2M YoY, with net income of $14.3M. TTV declined to $147.9M from $168.8M QoQ due to integration of new clients. MAUs were 9,760 in September, targeting 25,000 by December. The company plans a monthly 'Bakkt engine report' starting December. Strategic asset value grew to $145M, with plans for new embedded finance products and a cross-border trading desk.

$BKKTMed

Bakkt Q3 2026 slides: transformation done, volume targets aggressive

Bakkt Holdings reported Q3 2026 earnings, missing EPS estimates but showing strategic progress. The company completed its transformation and set aggressive transaction volume targets. Revenue declined 62.9% YoY to $149.2M, while net income was $14.3M. Management highlighted stablecoin infrastructure and cross-border payments as growth areas, aiming for $3B in 2026 and $6B in 2027 TTV.

$BKKTHigh

Bakkt Reports Third Quarter 2026 Results and Sets First-Half 2027 Total Transacting Volume Target of $6 Billion - Total Transacting Volume of $147.9 million…

Bakkt, Inc. (BKKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Bakkt Reports Third Quarter 2026 Results and Sets First-Half 2027 Total Transacting Volume Target of $6 Billion - Total Transacting Volume (“TTV”) of $147.9 million in Q3 bringing nine-month TTV to $557.9 million - Company reiterates its $3 billion full-year 2026 TTV target1 - Es